AI-Driven Drug Discovery: Hype or Healthcare Breakthrough?
Clinical trials, biotech research and drug discovery could all be accelerated by AI, industry experts say. But what does that mean for achieving the long-awaited medical breakthroughs people care about most, such as cancer treatments and therapies for rare diseases? Our guests explain how AI-driven medicines are moving closer to patients. Featuring: Emily Fang (InFocus Therapeutics) and Servina Liu (Taiwan Biomedical Innovation Association) Host: Divya Gopalan
